Publication | Closed Access
Structure-based identification of new orally bioavailable BRD9-PROTACs for treating acute myelocytic leukemia
13
Citations
27
References
2023
Year
Hematological MalignancyPharmaceutical ScienceStructure-based IdentificationMedicineMixed-phenotype Acute LeukemiaBioavailable Brd9-protacsAnti-cancer AgentBiomolecular EngineeringPharmacologyAcute Myelocytic LeukemiaCancer ResearchDrug Discovery
| Year | Citations | |
|---|---|---|
Page 1
Page 1